Ajay Gopal, MD, Oncology, Seattle, WA, Seattle Cancer Care Alliance

AjayKumarGopalMD

OncologySeattle, WA

Hematologic Oncology

Professor, Medicine, University of Washington School of Medicine: Member, Fred Hutchinson Cancer Research Center; Clinical Research Director- Hematologic Malignancies- Seattle Cancer Care Alliance

Overview of Dr. Gopal

Dr. Ajay Gopal is an oncologist in Seattle, WA and is affiliated with multiple hospitals in the area, including University of Washington Medical Center and Seattle Cancer Care Alliance. He received his medical degree from Emory University School of Medicine and has been in practice 24 years. He specializes in hematologic oncology and is experienced in hematologic oncology, Hodgkin’s lymphoma, non-Hodgkin’s Lymphoma, CLL, transplant, and cellular therapy.

Education & Training

  • University of Washington
    University of WashingtonFellowship
  • Duke University Hospital
    Duke University HospitalResidency
  • Emory University School of Medicine
    Emory University School of MedicineMedicalSchool

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 1997 - 2022
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • High Rate of Exclusion of HIV Infected Patients from Modern Lymphoma Studies: An Analysis of Current United States Therapeutic Trials
    Ajay K. Gopal, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Ibrutinib Selects for Cells with Elevated Reactive Oxygen Species and Downregulated Phosphatases
    Ajay K. Gopal, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • AG-636 for the Treatment of Adults with Advanced Lymphoma: Initiation of a Phase 1 Clinical Study
    Ajay K. Gopal, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Lectures

  • Indolent Lymphomas: The Marathon Has a New Course 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Axicabtagene Ciloleucel in the Real World: Outcomes and Predictors of Response, Resistance and Toxicity 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • The Alpha Emitter Astatine-211 Targeted to CD38 Can Eradicate Multiple Myeloma in Minimal Residual Disease Models 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Join now to see all

Press Mentions

  • Oral Duvelisib Potential New Option for Indolent Non-Hodgkin Lymphoma
  • One Family, Two Sides of CancerOctober 06, 2017

Grant Support

  • Radioimmunotherapy For LymphomaNational Cancer Institute2011
  • Radiolabeled Antibody Therapy Of B-Cell LymphomaNational Cancer Institute2005–2009
  • Proapoptotic Therapy For B-Cell NON Hodgkin'S LymphomaNational Cancer Institute2006–2007
  • Optimizing Radioimmunotherapy For NON Hodgkin'S LymphomaNational Cancer Institute2000–2005

Professional Memberships

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
    BCBS Blue Card PPO
    First Choice
    Health Net Oregon PPO
    Multiplan PPO
    ODS Network
    Premera BCBS Heritage & Heritage Plus 1
    Providence Health System Personal Option
    Regence Washington - Preferred Provider Network
    Sagamore Health Plus
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment